February 2017

Features

Direct Oral Anticoagulants for the Prevention of Stroke in Nonvalvular Atrial Fibrillation

Several DOACs (edoxaban, apixaban, rivaroxaban, dabigatran) have recently gained approval for use in NVAF.

Management of Coronary Artery Disease and Chronic Stable Angina

Angina pectoris, characterized by discomfort typically located in the chest, neck, or left arm, is one of several clinical manifestations of CAD.

Patient Teaching Aid: Arrhythmia

In arrhythmia, the heart beats too fast, too slowly, or randomly. View a new PTA Video about arrhythmia.

Primary and Secondary Prevention of Heart Disease

Interventions by pharmacists lead to reductions in risk factors for coronary heart disease.

Recognizing and Treating Venous Stasis Ulcers

Primary risk factors include older age, previous leg injury, deep venous thrombosis, and phlebitis.

Triple Therapy for a Cardiac Indication in a Veteran Population

The use of triple therapy after percutaneous coronary intervention is becoming more common.

Updated Treatment Options in the Management of Hyperkalemia

Patiromer was recently approved for chronic hyperkalemia, and other medications are in development.

Biosimilars in Oncology

WEB EXCLUSIVE: With the patents set to expire for a number of monoclonal antibodies, interest related to cancer biosimilars has expanded.

Pharmacotherapy Updates for Adult Soft-Tissue Sarcomas

WEB EXCLUSIVE: Cases of soft-tissue sarcoma are generally underreported because they often are asymptomatic and lymph node development is infrequent.

Consult Your Pharmacist

OTC Supplements for the Management of High Cholesterol

Nonprescription options that may be beneficial include immediate-release niacin, omega-3 fatty acids, and soluble fiber.

Contemporary Compounding

Furosemide 10 mg/mL Oral Suspension

Furosemide is used to treat edema associated with various disorders, as well as adjunctively to treat acute pulmonary edema.

Editorial

Taking Patient Counseling to Heart

The counseling of cardiovascular patients by pharmacists has a potentially enormous health-outcomes payoff.

Pharmacy Focus

Cardiometabolic Syndrome: A Global Health Issue

About 25% of adults worldwide have cardiometabolic syndrome, a combination of metabolic dysfunctions that is challenging to treat and burdensome to healthcare systems.

Senior Care

Myocardial Infarction in Women: Milder Symptoms, Aspirin, and Angioplasty

While positive outcomes with drugs and treatments require prompt intervention, ideally at the first sign of distress, about one-third of women do not experience chest pain when having a heart attack.

What's News

Web Exclusive

Biosimilars in Oncology

WEB EXCLUSIVE: With the patents set to expire for a number of monoclonal antibodies, interest related to cancer biosimilars has expanded.

Pharmacotherapy Updates for Adult Soft-Tissue Sarcomas

WEB EXCLUSIVE: Cases of soft-tissue sarcoma are generally underreported because they often are asymptomatic and lymph node development is infrequent.